[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @MarketPulse360 Market Pulse 360° Market Pulse 360° posts on X about india, dr reddys, $rdy, sanofi the most. They currently have XX followers and XX posts still getting attention that total X engagements in the last XX hours. ### Engagements: undefined [#](/creator/twitter::1517444811296587777/interactions)  - X Week XXX +12% - X Month XXX +100% - X Months XXXXX +634% - X Year XXXXXX +421% ### Mentions: undefined [#](/creator/twitter::1517444811296587777/posts_active)  - X Week X +50% - X Month XX +129% - X Months XX +81% - X Year XX +152% ### Followers: XX [#](/creator/twitter::1517444811296587777/followers)  - X Week XX -XXXX% - X Month XX +1.60% - X Months XX +25% ### CreatorRank: undefined [#](/creator/twitter::1517444811296587777/influencer_rank)  ### Social Influence [#](/creator/twitter::1517444811296587777/influence) --- **Social category influence** [countries](/list/countries) XXXX% [stocks](/list/stocks) XXXX% **Social topic influence** [india](/topic/india) 4.76%, [dr reddys](/topic/dr-reddys) 4.76%, [$rdy](/topic/$rdy) 4.76%, [sanofi](/topic/sanofi) XXXX% **Top assets mentioned** [Dr. Reddy's Laboratories Limited American Depositary Shares (RDY)](/topic/$rdy) [Sanofi (SNY)](/topic/sanofi) ### Top Social Posts [#](/creator/twitter::1517444811296587777/posts) --- Top posts by engagements in the last XX hours "Dr. Reddy's Launches Sanofi's Beyfortus in India for RSV Prevention #DRREDDY $RDY ➡ Dr. Reddys Laboratories has launched Beyfortus (nirsevimab) in India a preventive treatment for Respiratory Syncytial Virus (RSV) in infants following an expanded partnership with Sanofi. ➡ RSV is a significant yet underreported health crisis in India causing many respiratory infections in infants with experts reporting over 2000 child deaths in 2024 from Kolkata Bengaluru and Mumbai alone. ➡ According to the Article Beyfortus launch aligns with Dr. Reddy's dual-track growth strategy strengthening its core"  [@MarketPulse360](/creator/x/MarketPulse360) on [X](/post/tweet/1945970502436020389) 2025-07-17 22:14:56 UTC XX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Market Pulse 360° posts on X about india, dr reddys, $rdy, sanofi the most. They currently have XX followers and XX posts still getting attention that total X engagements in the last XX hours.
Social category influence countries XXXX% stocks XXXX%
Social topic influence india 4.76%, dr reddys 4.76%, $rdy 4.76%, sanofi XXXX%
Top assets mentioned Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) Sanofi (SNY)
Top posts by engagements in the last XX hours
"Dr. Reddy's Launches Sanofi's Beyfortus in India for RSV Prevention #DRREDDY $RDY ➡ Dr. Reddys Laboratories has launched Beyfortus (nirsevimab) in India a preventive treatment for Respiratory Syncytial Virus (RSV) in infants following an expanded partnership with Sanofi. ➡ RSV is a significant yet underreported health crisis in India causing many respiratory infections in infants with experts reporting over 2000 child deaths in 2024 from Kolkata Bengaluru and Mumbai alone. ➡ According to the Article Beyfortus launch aligns with Dr. Reddy's dual-track growth strategy strengthening its core" @MarketPulse360 on X 2025-07-17 22:14:56 UTC XX followers, XXX engagements
/creator/twitter::MarketPulse360